(T-PLL) |
T-cell prolymphocytic leukemia |
AKT |
serine/threonine-specific protein kinase |
ALL |
acute lymphoblastic leukemia |
AML |
acute myeloid leukemia |
BiTE |
bispecific T-cell engaging |
B-NHL |
B-cell non-Hodgkin lymphoma |
CAR |
chimeric antigen receptor |
CLL |
chronic lymphocytic leukemia |
COVID 19 |
coronavirus disease 2019 |
CRES |
CAR T-cell-related encephalopathy syndrome |
CRP |
C-reactive protein |
CRS |
cytokine release syndrome |
CSF |
colony-stimulating factor |
DLBCL |
diffuse Large B-cell Lymphoma |
FDA |
Food and Drug Administration |
GCSF |
granulocyte colony-stimulating factor |
HGF |
hepatocyte growth factor |
HLH |
haemophagocytic lymphohistiocytosis |
HSCT |
hematopoietic stem cell transplantation |
ICU |
intensive care unit |
IFN |
interferon |
IL |
interleukin |
IL6R |
IL6 Receptor |
IP-10 |
interferon–inducible protein 10 |
JAK |
Janus associated kinase |
mAbs |
monoclonal antibodies |
MAPK |
mitogen-activated protein kinase |
MAS |
macrophage activation syndrome |
MCP |
monocyte chemoattractant protein |
MIP |
macrophage inflammatory protein 1α |
MSC |
mesenchymal stem cells |
NHL |
non-Hodgkin lymphoma |
NK |
natural killer |
PT |
prothrombin time |
PTT |
partial thromboplastin time |
SARS-CoV-2 |
severe acute respiratory syndrome coronavirus 2 |
sIL6R |
soluble IL6 receptor |
SS |
Sézary syndrome |
STAT |
signal transducer and activator of transcription |
TGF |
transforming growth factors |
TNF |
tumor necrosis factors |